Breast Biopsy Market – Overview
Increased cancer detection rates globally have contributed to a rise in biopsy procedures. Market reports connected with the healthcare industry have been presented by Market Research Future which makes reports on other industry verticals that aims to analyze the current market scenarios better. The market is projected to develop at a favorable CAGR rate in the forecast 2018-2023.
Free Sample Copy of With Considering Coivd19 Impact on this Market @ https://www.marketresearchfuture.com/sample_request/6288
The prevalence of breast cancer has led to an increased level of reliance on breast biopsy procedures. Improved screening campaigns are also increasing the need for breast biopsy procedures. Furthermore, the rise in the awareness regarding cancer is anticipated to further motivate the expansion of the breast biopsy market in the forecast period.
Competitive Analysis:
Leading players in the global Biopsy Breast Market Procedure include Sonocine Inc., Toshiba Corporation, Gamma Medica Inc., Aurora Imaging Technology Inc., Dilon Technologies Inc., Fujifilm Holdings Corporation, Hologic Inc., Koninklijke Philips N.V., Siemens, and GE.
In September 2019, Candelis Inc. launched a new Advanced Breast Imaging Workstation as an enhancement to its ImageGrid platform.
Segmentation:
The breast cancer market has been segmented on the basis of product, technique type, guidance technology, and end-user. On the basis of product, the market has been classified as biopsy needles, biopsy tables, biopsy wires, and guidance systems. On the basis of technique type, the market is classified into fine needle aspiration biopsy, core needle biopsy, biopsy markers, MRI-guided core needle biopsy, incisional biopsy, excisional biopsy, wire localization, and sentinel node biopsy. Further, the core needle biopsy subsegment is segmented into stereotactic core needle biopsy, vacuum-assisted biopsy, ultrasound-guided core biopsy, and freehand core-needle biopsy. The surgical biopsy sub-segment is segmented into incisional biopsy and excisional biopsy. On the basis of guidance technology, the market is classified into ultrasound-guided, mammography-guided magnetic resonance, CT-guided biopsy, and other image-guided breast biopsy (PET and thermography). On the basis of end-user, the market is divided into hospitals, ambulatory surgical centers, diagnostic centers, and others
Regional Analysis:
The Americas is the largest regional market for breast imaging. The widespread awareness about breast cancer in the region has been a primary driver for the breast imaging market, as it has driven consistent product development in the breast imaging market. Women in the country don’t view breast cancer as a taboo and are proactive in fighting the disease on their own terms. This has driven significant growth of the breast imaging market. The growing prevalence of breast cancer in the region is also likely to remain a major driver for the breast imaging market in the Americas.
Europe holds the second largest share in the global breast imaging market, followed by Asia Pacific. China, Japan, and India are likely to emerge as important markets in the coming years, enabling steady growth of the breast imaging market in Asia Pacific.
Key players
Some of the key players in the global breast biopsy market are Leica Biosystems, C.R. Bard Inc., NuVue Therapeutics, Argon Medical Devices, Inc., Becton, Dickinson and Company, Devicor Medical Products Inc. Hologic Inc. Argon Medical Devices, Cook Medical Incorporated, Encapsule Medical Devices LLC., Johnson & Johnson, Galini SRL, Intact Medical Corporation, Conceptus INC, Hologic Inc., Karl Storz GmbH & Co. Kg, and GE Healthcare.
LIST OF TABLES
Table 1 Breast Biopsy Market Industry Synopsis, 2018–2023
Table 2 Global Breast Biopsy Market Estimates & Forecast, 2018–2023, (USD Million)
Table 3 Global Breast Biopsy Market, by Region, 2018–2023, (USD Million)
Table 4 Global Breast Biopsy Market, by Diagnosis, 2018–2023, (USD Million)
Table 5 Global Breast Biopsy Market, by Treatment, 2018–2023, (USD Million)
Table 6 Global Breast Biopsy Market, by End-User, 2018–2023, (USD Million)
Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/breast-biopsy-market-6288
Browse Related Reports
Tracheostomy Products Market
Gastroparesis Treatment Market
Healthcare Asset Management Market
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
English
Arabic
Français
Español
Português
Türkçe
Dutch
Italiano
Russian
Romaian